Evidence map›Paper›PMID 32508873›Full record

ArticleFrontiers in genetics2020

Construction and Validation of a 13-Gene Signature for Prognosis Prediction in Medulloblastoma.

Chang Li, Han Zou, Zujian Xiong, Yi Xiong, Danielle F Miyagishima, Siyi Wanggou, Xuejun Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Medulloblastoma: biology and immunotherapy.Frontiers in immunology · 2025
    Review
  6. Survival-Related Genes on Chromosomes 6 and 17 in Medulloblastoma.International journal of molecular sciences · 2024
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Chang LiDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Han ZouDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Zujian XiongDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Yi XiongDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Danielle F MiyagishimaDepartment of Neurosurgery, Yale School of Medicine, New Haven, CT, United States.
Siyi WanggouDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Xuejun LiDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Central South University · CNXiangya Hospital Central South University · CNYale University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

gene signatureLASSOmedulloblastomaprognosisrisk score model

Identifiers

PMID32508873
PMCPMC7249855
OpenAlexW3016319044

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.